Protein Tyrosine Phosphatase, Non-Receptor Type 6
"Protein Tyrosine Phosphatase, Non-Receptor Type 6" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A Src-homology domain-containing protein tyrosine phosphatase found in the CYTOSOL of hematopoietic cells. It plays a role in signal transduction by dephosphorylating signaling proteins that are activated or inactivated by PROTEIN-TYROSINE KINASES.
| Descriptor ID |
D053824
|
| MeSH Number(s) |
D08.811.277.352.650.775.300.600 D08.811.277.352.650.775.700.200 D12.644.360.585.600 D12.644.360.800.200 D12.776.476.564.600 D12.776.476.800.200
|
| Concept/Terms |
Protein Tyrosine Phosphatase, Non-Receptor Type 6- Protein Tyrosine Phosphatase, Non-Receptor Type 6
- Protein Tyrosine Phosphatase, Non Receptor Type 6
- Protein Tyrosine Phosphatase, Nonreceptor Type 6
- SHP1 Protein Tyrosine Phosphatase
- Hematopoietic Cell Phosphatase
- Protein Tyrosine Phosphatase 1C
- Hematopoietic Cell-Specific Tyrosine Phosphatase SHP-1
- Hematopoietic Cell Specific Tyrosine Phosphatase SHP 1
- SHP-1 Phosphatase
- SHP 1 Phosphatase
- SHP1 Phosphatase
- SHP-1 Protein-Tyrosine Phosphatase
- Protein-Tyrosine Phosphatase, SHP-1
- SHP 1 Protein Tyrosine Phosphatase
- SHP-1 Tyrosine Phosphatase
- SHP 1 Tyrosine Phosphatase
- Tyrosine Phosphatase, SHP-1
- Haematopoietic Cell Phosphatase
|
Below are MeSH descriptors whose meaning is more general than "Protein Tyrosine Phosphatase, Non-Receptor Type 6".
- Chemicals and Drugs [D]
- Enzymes and Coenzymes [D08]
- Enzymes [D08.811]
- Hydrolases [D08.811.277]
- Esterases [D08.811.277.352]
- Phosphoric Monoester Hydrolases [D08.811.277.352.650]
- Protein Tyrosine Phosphatases [D08.811.277.352.650.775]
- Protein Tyrosine Phosphatases, Non-Receptor [D08.811.277.352.650.775.300]
- Protein Tyrosine Phosphatase, Non-Receptor Type 6 [D08.811.277.352.650.775.300.600]
- SH2 Domain-Containing Protein Tyrosine Phosphatases [D08.811.277.352.650.775.700]
- Protein Tyrosine Phosphatase, Non-Receptor Type 6 [D08.811.277.352.650.775.700.200]
- Amino Acids, Peptides, and Proteins [D12]
- Peptides [D12.644]
- Intracellular Signaling Peptides and Proteins [D12.644.360]
- Protein Tyrosine Phosphatases, Non-Receptor [D12.644.360.585]
- Protein Tyrosine Phosphatase, Non-Receptor Type 6 [D12.644.360.585.600]
- SH2 Domain-Containing Protein Tyrosine Phosphatases [D12.644.360.800]
- Protein Tyrosine Phosphatase, Non-Receptor Type 6 [D12.644.360.800.200]
- Proteins [D12.776]
- Intracellular Signaling Peptides and Proteins [D12.776.476]
- Protein Tyrosine Phosphatases, Non-Receptor [D12.776.476.564]
- Protein Tyrosine Phosphatase, Non-Receptor Type 6 [D12.776.476.564.600]
- SH2 Domain-Containing Protein Tyrosine Phosphatases [D12.776.476.800]
- Protein Tyrosine Phosphatase, Non-Receptor Type 6 [D12.776.476.800.200]
Below are MeSH descriptors whose meaning is more specific than "Protein Tyrosine Phosphatase, Non-Receptor Type 6".
This graph shows the total number of publications written about "Protein Tyrosine Phosphatase, Non-Receptor Type 6" by people in this website by year, and whether "Protein Tyrosine Phosphatase, Non-Receptor Type 6" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2017 | 2 | 2 | 4 |
| 2018 | 2 | 0 | 2 |
| 2019 | 0 | 1 | 1 |
To return to the timeline, click here.
Below are the most recent publications written about "Protein Tyrosine Phosphatase, Non-Receptor Type 6" by people in Profiles.
-
ZnAs@SiO2 nanoparticles as a potential anti-tumor drug for targeting stemness and epithelial-mesenchymal transition in hepatocellular carcinoma via SHP-1/JAK2/STAT3 signaling. Theranostics. 2019; 9(15):4391-4408.
-
The HNF1a-regulated lncRNA HNF1A-AS1 reverses the malignancy of hepatocellular carcinoma by enhancing the phosphatase activity of SHP-1. Mol Cancer. 2018 02 21; 17(1):63.
-
Hepatic leukocyte immunoglobulin-like receptor B4 (LILRB4) attenuates nonalcoholic fatty liver disease via SHP1-TRAF6 pathway. Hepatology. 2018 04; 67(4):1303-1319.
-
Suppression of PTPN6 exacerbates aluminum oxide nanoparticle-induced COPD-like lesions in mice through activation of STAT pathway. Part Fibre Toxicol. 2017 Dec 12; 14(1):53.
-
High mTOR activity is a hallmark of reactive natural killer cells and amplifies early signaling through activating receptors. Elife. 2017 09 06; 6.
-
Research on the epigenetic regulation mechanism of the PTPN6 gene in advanced chronic myeloid leukaemia. Br J Haematol. 2017 09; 178(5):728-738.
-
Dengue virus compartmentalization during antibody-enhanced infection. Sci Rep. 2017 01 13; 7:40923.